XRTX:NASDAQ, XORTX Therapeutics Inc.

Why XRTX stock rose on November 13

XORTX Therapeutics Inc. rose 19.6% on Friday, November 13, 2026, on 1,586,400 shares, 2.1 times its average daily volume. The headline around the move:

XRTX stock overview

XORTX Therapeutics Inc. (XRTX:NASDAQ) closed at $1.04 on November 16, 2026, down 5.45% on the day. The stock trades 71.1% below its 52-week high of $3.60 and 27.6% above its 52-week low of $0.815. Over the past year, it lost 62.3%. XORTX Therapeutics Inc. is part of the Health Care sector.

Key figures

Price
$1.04
Day change
-5.45%
Volume
926,407
Average volume
758,854
Market cap
1M+
52-week range
$0.815 – $3.60
50-day average
$1.47
200-day average
$2.04

Price action over the past year

In 252 trading sessions since November 14, 2025, XRTX closed higher on 107 days (42%). Its best day was April 8, 2026 (+30.70%) and its worst was October 9, 2026 (-23.78%). The stock moved 10% or more in a single session 25 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

XRTX news

About XORTX Therapeutics Inc.

XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.

Similar stocks

Find more stocks like XRTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.